Kommentar zu „MAMMA – Mammakarzinom: Staging mit der photonenzählenden CT“

Rofo 2024; 196(08): 776-777
DOI: 10.1055/a-2281-2065

Brennpunkt

Heike Preibsch

¹Institute for Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany

Literatur
1 Sardanelli F, Trimboli RM, Houssami N. et al. Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA). Eur Radiol 2022; 32: 1611-1623
2 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, 2021, AWMF Registernummer: 032–045OL. Accessed March 01, 2024 at: http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/
3 Schiaffino S, Cozzi A, Clauser P. et al. Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI). Eur Radiol 2024;
4 Wetzl M, Dietzel M, Ohlmeyer S. et al. Spiral breast computed tomography with a photon-counting detector (SBCT): The future of breast imaging?. Eur J Radiol 2022; 157: 110605
5 Stein T, Rau A, Russe MF. et al. Photon-Counting Computed Tomography – Basic Principles, Potenzial Benefits, and Initial Clinical Experience. Rofo 2023; 195: 691-698